Aster Launches Stock Perpetual Contracts for US Equities

Generated by AI AgentCoin World
Wednesday, Jul 16, 2025 7:52 pm ET2min read
Aime RobotAime Summary

- Aster (backed by YZi Labs) launched stock perpetual contracts for major US equities like Amazon and Apple, offering up to 50x leverage and decentralized access.

- The DEX enables 24/7 trading without intermediaries, signups, or paperwork, contrasting with traditional brokers' restrictions.

- CEO Leonard emphasized Aster's mission to bridge TradFi and DeFi, combining equity exposure with DeFi's privacy and speed advantages.

- With Pyth Network pricing and 2nd-largest perp DEX volume, the launch expands crypto traders' access to blue-chip equities.

Aster, a next-generation decentralized perpetual exchange (DEX) backed by YZi Labs, has launched a new asset type on Aster Pro, introducing stock perpetual contracts. This innovation allows traders to gain leveraged, permissionless exposure to leading US stocks, including

, , Alphabet, , , , and , with more blue-chip names expected to follow.

This development positions Aster as one of the few global perp DEXs offering stock-based perpetual futures, enabling users to diversify into equities without compromising on custody, privacy, or speed. Unlike traditional brokers, Aster provides decentralized access to global equity markets 24/7, eliminating the need for intermediaries. Users can enter positions anytime, anywhere with up to 50x leverage, without the hassle of signups, paperwork, or gatekeeping.

While liquidity may be lower outside of traditional US stock market hours, reflecting the current structure of global equity markets, traders can still manage smaller positions on Aster during this period. During Wall Street’s active hours, Aster’s deep liquidity pools offer smoother fills and efficient execution. With NASDAQ’s plan for 24/5 trading in the near future, traders will experience longer trading hours on Aster with deep liquidity and smooth execution.

Leonard, CEO of Aster, emphasized the company's mission to break down barriers in asset types, market hours, and outdated trading infrastructures. He stated, “With decentralized stock perpetual contracts, we’re opening the doors for crypto traders to access the biggest US equities with the privacy and speed they deserve.”

Similar to other perpetual contracts on Aster Pro, Aster’s stock perpetuals are derivative contracts that allow traders to speculate on the price of the underlying asset without the need for real-world custody. Pricing data for these contracts is derived directly from the Pyth Network, ensuring reliable and tamper-resistant feeds for stock contracts and all other Aster perpetual contracts. Traders will also benefit from Aster’s high-speed matching engine and integrated liquidity, which have made Aster the global second perp DEX by trading volume.

This launch marks a significant milestone in Aster’s mission to bridge traditional finance (TradFi) and decentralized finance (DeFi) without compromise. From a record-breaking first half of 2025 with over $58 billion in trading volume and the rollout of features like the Aster Mobile app, to unveiling hidden orders and Aster Chain Beta, Aster continues to elevate what DeFi can deliver with the launch of stock perpetual contracts. As the convergence of TradFi and DeFi gains traction worldwide, Aster is leading the charge, combining the hallmark privacy and composability of DeFi with new asset opportunities.

Users can start trading US equities with crypto and leverage, enjoying the freedom and flexibility that only Aster offers. Aster is a next-generation perp DEX built for everyone, offering MEV-free, one-click trading for crypto with up to 1001x leverage in simple mode and advanced tools including hidden orders, grid trading, and stock contracts in pro mode. Aster Chain is a high-performance blockchain engineered to deliver private and non-custodial onchain orderbook trading. Backed by YZi Labs, Aster is building the future of DeFi fast, flexible, and community-first.

Comments



Add a public comment...
No comments

No comments yet